On 11 November 2025, Livzon Pharmaceutical Group Inc. (Stock Code: 1513) announced the publication of its 2025 First Extraordinary General Meeting materials. These include a circular dated 11 November 2025, along with the meeting notice and proxy form, which are available on both the company’s website (www.livzon.com.cn) and The Stock Exchange of Hong Kong Limited’s website (www.hkexnews.hk).

The announcement states that shareholders who prefer receiving printed versions of these materials may complete and return the enclosed request form. Shareholders are also encouraged to provide a valid email address to ensure timely receipt of future corporate communications in electronic form.

To update contact details or request printed copies, shareholders can email 1513-ecom@vistra.com or send the completed request form to the company’s branch share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.